Literature DB >> 11173905

Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis.

K Ishizuka1, K Sugimura, T Homma, J Matsuzawa, T Mochizuki, M Kobayashi, K Suzuki, K Otsuka, K Tashiro, O Yamaguchi, H Asakura.   

Abstract

A decrease in the ratio of IL-1ra/IL-1 beta produced regionally by the colonic mucosa of patients with ulcerative colitis (UC) is believed to play a role in the pathogenesis of UC. To investigate factors influencing intramucosal IL-1ra/IL-1 beta ratios, we evaluated polymorphism of the IL-1ra gene and the production of mucosal cytokines in Japanese patients with UC. Colonic biopsy specimens of mucosal tissue were placed in organ cultures for 24 h. Then, the supernatant concentrations of IL-1 beta, IL-1ra, IL-8, IL-4, IL-10, and TGF-beta were assayed by ELISA. Genomic DNA was extracted from patient peripheral blood samples, then IL-1ra gene polymorphism was determined using PCR amplification. The mucosa from patients with active stage UC showed a tendency toward a decreased IL-1ra/IL-1 beta ratio. In the resolving stage, IL-1ra/IL-1 beta ratios increased with increasing IL-10 and TGF-beta concentrations. The addition of human recombinant IL-10 to the culture supernatants produced concentration-dependent inhibition of IL-1 beta. In Japanese patients with UC, the IL-1ra allele gene 2 phenotype had no effect on the IL-1ra/IL-1 beta ratio. Our findings suggest that a relative deficiency of IL-10 in patients with UC may contribute to persistent inflammatory changes. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11173905     DOI: 10.1159/000051906

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  12 in total

1.  Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population.

Authors:  J Matsuzawa; K Sugimura; Y Matsuda; M Takazoe; K Ishizuka; T Mochizuki; S S Seki; O Yoneyama; H Bannnai; K Suzuki; T Honma; H Asakura
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis.

Authors:  Hiroyuki Hanai; Takayuki Iida; Masami Yamada; Yoshihiko Sato; Ken Takeuchi; Tatsuo Tanaka; Kenji Kondo; Masataka Kikuyama; Yasuhiko Maruyama; Yasushi Iwaoka; Akiko Nakamura; Kazuhisa Hirayama; Abby R Saniabadi; Fumitoshi Watanabe
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.

Authors:  O Ludwiczek; E Vannier; I Borggraefe; A Kaser; B Siegmund; C A Dinarello; H Tilg
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

4.  Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis.

Authors:  Li Tian; Yu-Xin Huang; Min Tian; Wei Gao; Qing Chang
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

Review 5.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

Authors:  Ankit Saxena; Sam Khosraviani; Sanjeev Noel; Divya Mohan; Thomas Donner; Abdel Rahim A Hamad
Journal:  Cytokine       Date:  2014-12-04       Impact factor: 3.861

6.  Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.

Authors:  Benoit Foligné; Sophie Nutten; Lothar Steidler; Véronique Dennin; Denise Goudercourt; Annick Mercenier; Bruno Pot
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

7.  The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.

Authors:  Vibeke Andersen; Anja Ernst; Jane Christensen; Mette Østergaard; Bent A Jacobsen; Anne Tjønneland; Henrik B Krarup; Ulla Vogel
Journal:  BMC Med Genet       Date:  2010-05-28       Impact factor: 2.103

Review 8.  IL-10 and its related cytokines for treatment of inflammatory bowel disease.

Authors:  Ming-Cai Li; Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

9.  Association of -1087 IL10 and -308 TNFA gene polymorphisms with serological markers of coeliac disease.

Authors:  M Hahn-Zoric; A M Hytönen; L A Hanson; L A Nilsson; L Padyukov
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

Review 10.  Why interleukin-10 supplementation does not work in Crohn's disease patients.

Authors:  Gareth J Marlow; Dominique van Gent; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.